Company intelligence / Profile preview

Iron Path Capital

Nashville, Tennessee, United States

Ownership: Private
Development stage: Other

Overview

Iron Path Capital is an operationally focused private equity firm that raises funds (Fund I closed at $273M in 2024) to make control investments in lower middle‑market healthcare and specialty industrial businesses; it is an investor, not a therapeutic developer, so it has no clinical programs of its own.

Industry: Investors

Partnerships

Partnerships with portfolio companies such as VION Biosciences and Emergence Health (ClearChoiceMD + CareWell Urgent Care) as the financial sponsor.

Beyond the preview

Go deeper on Iron Path Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron Path Capital.

Explore the full profile